Transgender Women in the Female Category of Sport: Perspectives on Testosterone Suppression and Performance Advantage
- PMID: 33289906
- PMCID: PMC7846503
- DOI: 10.1007/s40279-020-01389-3
Transgender Women in the Female Category of Sport: Perspectives on Testosterone Suppression and Performance Advantage
Erratum in
-
Correction to: Transgender Women in the Female Category of Sport: Perspectives on Testosterone Suppression and Performance Advantage.Sports Med. 2021 Oct;51(10):2235. doi: 10.1007/s40279-021-01480-3. Sports Med. 2021. PMID: 33914284 Free PMC article. No abstract available.
Abstract
Males enjoy physical performance advantages over females within competitive sport. The sex-based segregation into male and female sporting categories does not account for transgender persons who experience incongruence between their biological sex and their experienced gender identity. Accordingly, the International Olympic Committee (IOC) determined criteria by which a transgender woman may be eligible to compete in the female category, requiring total serum testosterone levels to be suppressed below 10 nmol/L for at least 12 months prior to and during competition. Whether this regulation removes the male performance advantage has not been scrutinized. Here, we review how differences in biological characteristics between biological males and females affect sporting performance and assess whether evidence exists to support the assumption that testosterone suppression in transgender women removes the male performance advantage and thus delivers fair and safe competition. We report that the performance gap between males and females becomes significant at puberty and often amounts to 10-50% depending on sport. The performance gap is more pronounced in sporting activities relying on muscle mass and explosive strength, particularly in the upper body. Longitudinal studies examining the effects of testosterone suppression on muscle mass and strength in transgender women consistently show very modest changes, where the loss of lean body mass, muscle area and strength typically amounts to approximately 5% after 12 months of treatment. Thus, the muscular advantage enjoyed by transgender women is only minimally reduced when testosterone is suppressed. Sports organizations should consider this evidence when reassessing current policies regarding participation of transgender women in the female category of sport.
Conflict of interest statement
Emma N Hilton and Tommy R Lundberg declare that they have no conflict of interest with the content of this review.
Figures

Comment in
-
Comment on: "Transgender Women in the Female Category of Sport: Perspectives on Testosterone Suppression and Performance Advantage".Sports Med. 2024 Jan;54(1):237-242. doi: 10.1007/s40279-023-01928-8. Epub 2023 Sep 20. Sports Med. 2024. PMID: 37726582 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous